Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 578128, 11 pages
http://dx.doi.org/10.1155/2011/578128
Research Article

The Construction of Chimeric T-Cell Receptor with Spacer Base of Modeling Study of VHH and MUC1 Interaction

1Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran
2Department of Biochemistry, Biological Science, Tarbiat Modares University, Tehran, Iran
3National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
4Department of Medical Biotechnology, Tarbiat Modares University, Tehran, Iran

Received 19 March 2011; Revised 24 May 2011; Accepted 2 June 2011

Academic Editor: Ayman El-Kadi

Copyright © 2011 Nazanin Pirooznia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. H. June, “Principles of adoptive T cell cancer therapy,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1204–1212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Yee, “Adoptive T-Cell Therapy of Cancer,” Hematology/Oncology Clinics of North America, vol. 20, no. 3, pp. 711–733, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Tey, C. M. Bollard, and H. E. Heslop, “Adoptive T-cell transfer in cancer immunotherapy,” Immunology and Cell Biology, vol. 84, no. 3, pp. 281–289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Barry and R. C. Bleackley, “Cytotoxic T lymphocytes: all roads lead to death,” Nature Reviews Immunology, vol. 2, no. 6, pp. 401–409, 2002. View at Google Scholar · View at Scopus
  5. W. Y. Ho, C. Yee, and P. D. Greenberg, “Adoptive therapy with CD8+ T cells: it may get by with a little help from its friends,” Journal of Clinical Investigation, vol. 110, no. 10, pp. 1415–1417, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. C. H. June, “Adoptive T cell therapy for cancer in the clinic,” Journal of Clinical Investigation, vol. 117, no. 6, pp. 1466–1476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Murphy, J. A. Westwood, L. E. Brown et al., “Antitumor activity of dual-specific T cells and influenza virus,” Cancer Gene Therapy, vol. 14, no. 5, pp. 499–508, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Eshhar, “The T-body approach: redirecting T cells with antibody specificity,” Handbook of experimental pharmacology, no. 181, pp. 329–342, 2008. View at Google Scholar · View at Scopus
  9. A. Hombach, A. Wieczarkowiecz, T. Marquardt et al., “Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule,” Journal of Immunology, vol. 167, no. 11, pp. 6123–6131, 2001. View at Google Scholar · View at Scopus
  10. K. Kronfeld, E. Hochleitner, S. Mendler et al., “B7/CD28 costimulation of T cells induces a distinct proteome pattern,” Molecular and Cellular Proteomics, vol. 4, no. 12, pp. 1876–1887, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Karplus, “Dynamics of proteins,” Advances in Biophysics, vol. 18, pp. 165–190, 1984. View at Google Scholar · View at Scopus
  12. M. Karplus and J. A. McCammon, “The dynamics of proteins,” Scientific American, vol. 254, no. 4, pp. 42–51, 1986. View at Google Scholar · View at Scopus
  13. M. Karplus, S. Swaminathan, T. Ichiye, and W. F. Van Gunsteren, “Local and collective motions in protein dynamics,” Ciba Foundation Symposium, vol. 93, pp. 271–290, 1983. View at Google Scholar · View at Scopus
  14. W. R. Cannon, S. F. Singleton, and S. J. Benkovic, “A perspective on biological catalysis,” Nature Structural Biology, vol. 3, no. 10, pp. 821–833, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. P. Williams, “Are enzymes mechanical devices?” Trends in Biochemical Sciences, vol. 18, no. 4, pp. 115–117, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. T. A. Sulchek, R. W. Friddle, K. Langry et al., “Dynamic force spectroscopy of parallel individual Mucin1-antibody bonds,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 46, pp. 16638–16643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Webster, Protein Structure Prediction: Methods and Protocols (Methods in Molecular Biology), vol. 143, Humana Press, Totowa, NJ, USA, 2000.
  18. D. A. Case, T. A. Darden, T. E. Cheatham III et al., AMBER: Version 9, University of California, San Francisco, Calif, USA, 2004.
  19. Y. Duan, C. Wu, S. Chowdhury et al., “A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations,” Journal of Computational Chemistry, vol. 24, no. 16, pp. 1999–2012, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Darden, D. York, and L. Pedersen, “Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems,” The Journal of Chemical Physics, vol. 98, no. 12, pp. 10089–10092, 1993. View at Google Scholar · View at Scopus
  21. W. L. Jorgensen, J. Chandrasekhar, J. D. Madura, R. W. Impey, and M. L. Klein, “Comparison of simple potential functions for simulating liquid water,” The Journal of Chemical Physics, vol. 79, no. 2, pp. 926–935, 1983. View at Google Scholar · View at Scopus
  22. P. Aloy, G. Moont, H. A. Gabb, E. Querol, F. X. Aviles, and M. J. E. Sternberg, “Modelling repressor proteins docking to DNA,” Proteins, vol. 33, no. 4, pp. 535–549, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. S. H. A. Bakhtiari, F. Rahbarizadeh, S. Hasannia, D. Ahmadvand, F. J. Iri-Sofla, and M. J. Rasaee, “Anti-MUC1 nanobody can redirect T-body cytotoxic effector function,” Hybridoma, vol. 28, no. 2, pp. 85–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Xue, R. Gillmore, A. Downs et al., “Exploiting T cell receptor genes for cancer immunotherapy,” Clinical and Experimental Immunology, vol. 139, no. 2, pp. 167–172, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Coccoris, M. A. de Witte, and T. N. M. Schumacher, “Prospects and limitations of T cell receptor gene therapy,” Current Gene Therapy, vol. 5, no. 6, pp. 583–593, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Eshhar, “The T-body approach: redirecting T cells with antibody specificity,” Handbook of Experimental Pharmacology, no. 181, pp. 329–342, 2008. View at Google Scholar · View at Scopus
  27. A. Hombach and H. Abken, “Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy,” Cancer Immunology, Immunotherapy, vol. 56, no. 5, pp. 731–737, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Kronfeld, E. Hochleitner, S. Mendler et al., “B7/CD28 costimulation of T cells induces a distinct proteome pattern,” Molecular and Cellular Proteomics, vol. 4, no. 12, pp. 1876–1887, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Murphy, J. A. Westwood, L. E. Brown et al., “Antitumor activity of dual-specific T cells and influenza virus,” Cancer Gene Therapy, vol. 14, no. 5, pp. 499–508, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Thistlethwaite, W. Mansoor, D. E. Gilham, and R. E. Hawkins, “Engineering T-cells with antibody-based chimeric receptors for effective cancer therapy,” Current Opinion in Molecular Therapeutics, vol. 7, no. 1, pp. 48–55, 2005. View at Google Scholar · View at Scopus
  31. T. A. Sulchek, R. W. Friddle, K. Langry et al., “Dynamic force spectroscopy of parallel individual Mucin1-antibody bonds,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 46, pp. 16638–16643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Li and P. J. Cozzi, “MUC1 is a promising therapeutic target for prostate cancer therapy,” Current Cancer Drug Targets, vol. 7, no. 3, pp. 259–271, 2007. View at Publisher · View at Google Scholar · View at Scopus